JPRN-UMIN000003775已完成未知
Adding of sitagliptin phosphate hydrate to combination therapy with pegylated interferon alpha 2b and ribavirin for patients with chronic hepatitis C and diabetes mellitus - ASPIRIN trial
Department of Hepatology, Osaka City University0 个研究点目标入组 50 人开始时间: 2010年6月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
Enrolled patients were few. Now, new anti-HCV drugs were available for patients with chronic hepatitis C. We decide the discontinuation of the present study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •pregnant woman drug allergy insulin medication depression autoimmune diseases malignant diseases
研究者
相似试验
已完成
不适用
The beneficial effect and safety Eldecalcitol with combined peginterferon alpha-2a plus ribavirin for chronic hepatitis C patients with osteoporosisChronic hepatitis C with osteoporosisJPRN-UMIN000006285Department of Hepatology, Osaka City University50
已完成
不适用
Addressing low treatment rates of chronic hepatitis C in injecting drug usersHepatitis C virus treatmentInfections and InfestationsAcute hepatitis CISRCTN07774040Barts and the London NHS Trust (UK)402
Unknown
4 期
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsChronic Hepatitis BNCT02337127Kaohsiung Medical University Chung-Ho Memorial Hospital500
已完成
4 期
SMV + SOF With/Without RBV for IFN-II Patients With CHCHepatitis CNCT02214420SC Liver Research Consortium, LLC24
尚未招募
2 期
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 for the Treatment of Virally-Suppressed Subjects with Chronic Hepatitis BACTRN12614000628640Gilead Sciences, Inc.150